Walleye Capital
ONC

Walleye Capital’s BeOne Medicines Ltd ONC Stock Holding History

Walleye Capital’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$89.1K Buy
+300
New +$97.1K ﹤0.01% 3712
2024
Q2 		– Sell
-400
Closed -$62.6K – 6095
2024
Q1 		$62.6K Buy
400
+200
+100% +$32.2K ﹤0.01% 4602
2023
Q4 		$36.1K Sell
200
-100
-33% -$18.1K ﹤0.01% 4377
2023
Q3 		$54K Sell
300
-3,100
-91% -$613K ﹤0.01% 4171
2023
Q2 		$606K Buy
3,400
+3,300
+3,300% +$760K ﹤0.01% 2283
2023
Q1 		$21.6K Sell
100
-100
-50% -$24K ﹤0.01% 3392
2022
Q4 		$44K Buy
+200
New +$36.7K ﹤0.01% 2553

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Walleye Capital's ONC Position: Q1 2026 in Review

Walleye Capital increased its BeOne Medicines Ltd (ONC) stake by 616% in Q1 2026, buying an estimated $5.86M and bringing the position to 21,051 shares worth $6.25M. The position accounts for 0.03% of the portfolio, ranked #659.

Walleye Capital first reported a position in ONC in Q3 2023 and has held it in 9 quarters since. The position peaked at $19.8M in Q1 2025. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Walleye Capital held 21,051 shares of BeOne Medicines Ltd worth $6.25M as of Q1 2026.
  • Walleye Capital bought 18,109 BeOne Medicines Ltd shares in Q1 2026, an estimated $5.86M.
  • BeOne Medicines Ltd made up 0.03% of Walleye Capital's portfolio in Q1 2026, its #659 holding.
  • Walleye Capital first reported a position in BeOne Medicines Ltd in Q3 2023 and has held it in 9 quarters since.
  • Walleye Capital's BeOne Medicines Ltd position peaked at $19.8M in Q1 2025.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.